Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahul N Prasad

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuro-Oncology|June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysisJoshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Frontiers in Oncology|December 12, 2022
Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapyKhaled Dibs, Joshua D Palmer, Rahul N Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Cancer|January 25, 2022
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter studyEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Journal of Neuro-Oncology|October 27, 2023
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patientsEric J Lehrer, Atulya A Khosla, Ahmad Ozair, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Neuro-Oncology|June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysisJoshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Frontiers in Oncology|December 12, 2022
Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapyKhaled Dibs, Joshua D Palmer, Rahul N Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 24, 2024
Tyrosine Kinase Inhibitors With and Without Up-Front Stereotactic Radiosurgery for Brain Metastases From <i>EGFR</i> and <i>ALK</i> Oncogene-Driven Non-Small Cell Lung Cancer (TURBO-NSCLC)Luke R G Pike, Emily Miao, Lillian A Boe, et al.
Cancer|January 25, 2022
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter studyEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Journal of Neuro-Oncology|October 27, 2023
Immune checkpoint inhibition and single fraction stereotactic radiosurgery in brain metastases from non-small cell lung cancer: an international multicenter study of 395 patientsEric J Lehrer, Atulya A Khosla, Ahmad Ozair, et al.
Pageof 3